Search this website. You can use fund codes to locate specific funds

Facilitating collaborative engagement on climate change

Engagement case study

Fast reading

  • Hermes EOS has actively engaged with some of the world’s largest emitters of greenhouse gasses, asking for development of more sustainable long-term business models, reductions in greenhouse gas emissions and improved governance and disclosure.
  • With the UN Climate Change Conference of the Parties over the next two weeks, we revisit our case study on the progress we have made over 2018-2019 in pursuit of climate-related engagement objectives, first published by the Principles for Responsible Investment in September this year.

Case studies are shown to demonstrate engagement, EOS does not make any investment recommendations and the information is not an offer to buy or sell securities.

Related Insights

Climate change and human rights
Climate change is not only having a devastating impact on the environment, it is also a human rights issue.
NetEase case study
NetEase published its inaugural ESG report in June 2020, covering material ESG topics including data privacy and protection, and GDPR compliance. EOS is pleased with its commitment to improve shareholder communication and continues to engage with the company on the wider ESG agenda.
HEINEKEN case study
HEINEKEN has improved the standard and transparency of its business conduct policies, increasing investor confidence. EOS continues to engage with the company on its accountability to its key values of integrity and fairness and on other ESG issues.
Takeda Pharmaceutical case study
Takeda Pharmaceutical has significantly improved the transparency and accountability of its executive remuneration, aligning itself more closely to global peers. EOS has engaged it on this topic for the past 16 months to increase investor confidence in the company for the long term.
Burberry case study
Burberry has reaffirmed its commitment to find alternatives to incinerating surplus stock in the midst of the coronavirus pandemic and set a science-based carbon reduction target.
The coronavirus and the race for a vaccine
With the coronavirus pandemic set to continue without an effective and widely-available vaccine, all eyes are on the pharmaceutical sector.

EOS Client Service and Business Development

Amy D’Eugenio,
Head of Client Service and Business Development, EOS